197 related articles for article (PubMed ID: 10732738)
1. The promise of anti-angiogenic cancer therapy.
Oehler MK; Bicknell R
Br J Cancer; 2000 Feb; 82(4):749-52. PubMed ID: 10732738
[No Abstract] [Full Text] [Related]
2. Angiogenesis and cancer: recent advances.
Cáceres W; González S
P R Health Sci J; 2003 Jun; 22(2):149-51. PubMed ID: 12866139
[TBL] [Abstract][Full Text] [Related]
3. [Progress in the lung cancer therapy with angiogenesis inhibitors].
Bai C; Ma T
Zhonghua Jie He He Hu Xi Za Zhi; 1998 May; 21(5):306-7. PubMed ID: 11326959
[No Abstract] [Full Text] [Related]
4. [Therapeutic prospects of angiogenesis inhibitors in cancerology].
Bout JC; Soncin F; Vandenbunder B
Rev Mal Respir; 1999 Nov; 16(5):854-5. PubMed ID: 10612161
[No Abstract] [Full Text] [Related]
5. [The clinical perspective of angiogenesis inhibitors].
Radema SA; Witteveen PO; Gebbink MB; Voest EE
Ned Tijdschr Geneeskd; 2003 Aug; 147(35):1675-80. PubMed ID: 14513538
[TBL] [Abstract][Full Text] [Related]
6. Cancer "breakthrough" is still in the future.
Health News; 1998 Jun; 4(7):6. PubMed ID: 9624918
[No Abstract] [Full Text] [Related]
7. Are angiostatin and endostatin cures for cancer?
Harris AL
Lancet; 1998 May; 351(9116):1598-9. PubMed ID: 9620709
[No Abstract] [Full Text] [Related]
8. Cancer 'cure' article stirs up hot debate.
Wadman M
Nature; 1998 May; 393(6681):104-5. PubMed ID: 9603508
[No Abstract] [Full Text] [Related]
9. [Antiangiogenic therapy].
Toi M
Gan To Kagaku Ryoho; 1998 Nov; 25(13):2003-9. PubMed ID: 9838900
[TBL] [Abstract][Full Text] [Related]
10. Problems with media gatekeepers.
Nature; 1998 May; 393(6681):97. PubMed ID: 9603503
[No Abstract] [Full Text] [Related]
11. Folkman looks ahead. The controversial pioneer of angiogenesis is back on the map--and now his theories are being tested on humans.
Kalb C
Newsweek; 2001 Feb; 137(8):44-5. PubMed ID: 11225089
[No Abstract] [Full Text] [Related]
12. Angiogenesis: the unifying concept in cancer?
Saphir A
J Natl Cancer Inst; 1997 Nov; 89(22):1658-9. PubMed ID: 9390530
[No Abstract] [Full Text] [Related]
13. Angiostatin and endostatin: endogenous inhibitors of tumor growth.
Sim BK; MacDonald NJ; Gubish ER
Cancer Metastasis Rev; 2000; 19(1-2):181-90. PubMed ID: 11191058
[TBL] [Abstract][Full Text] [Related]
14. Role of angiogenesis in tumor growth and metastasis.
Folkman J
Semin Oncol; 2002 Dec; 29(6 Suppl 16):15-8. PubMed ID: 12516034
[TBL] [Abstract][Full Text] [Related]
15. Antitumor interaction of short course endostatin and ionizing radiation.
Greenberger JS
Cancer J; 2000; 6(5):279-81. PubMed ID: 11079164
[No Abstract] [Full Text] [Related]
16. Anticancer drug targets: approaching angiogenesis.
Keshet E; Ben-Sasson SA
J Clin Invest; 1999 Dec; 104(11):1497-501. PubMed ID: 10587512
[No Abstract] [Full Text] [Related]
17. [The story of angiostatin and how controversy is useful in science].
Kurjak A
Acta Med Croatica; 2003; 57(2):145-8. PubMed ID: 12879695
[TBL] [Abstract][Full Text] [Related]
18. Shouting 'cure!'--or whispering 'hope'--in a crowded cancer ward.
Healy BP
J Womens Health; 1998 Jun; 7(5):489-90. PubMed ID: 9650147
[No Abstract] [Full Text] [Related]
19. Cancer experts offer healthy dose of skepticism toward hype over antiangiogenesis agents.
Phillips P
JAMA; 1998 Jun; 279(24):1936-7. PubMed ID: 9643843
[No Abstract] [Full Text] [Related]
20. [Endostatin--light on the treatment of cancer in mice].
Porkka K
Duodecim; 1997; 113(22):2241-3. PubMed ID: 10892128
[No Abstract] [Full Text] [Related]
[Next] [New Search]
